Evaluation of high sensitive C-reactive protein and 5-10 methylenetetrahydrofolate reductase genotype in Japanese young adults

References

• BARBEAU, P., LITAKER, M. S., WOODS, K. F., LEMMON, C. R., HUMPHRIES, M. C., OWEN SS. and Gu-riN, B. 2002, Hemostatic and inflammatory markers in obese youths: effects of exercise and adiposity. Journal of Pediatrics, 141, 415–420.
   Google Scholar
• COOK, D. G., MENDALL, M. A., WHINCUP, P. H., CAREY, I. M., BALI-AM, L, MORRIS, J. E., MILLER, G. J. and STRACHAN, D. P. 2000, C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis, 149, 139–150.
   Google Scholar
• CTJSHMAN, M., LEGAULT, C., BARRETT-CONNOR, E., STEFANICK, M. L., KESSLER, C., JUDD, H. L., SAKKINEN, P. A. and TRACY, R P. 1999, Effect of postmenopausal hormones on inflammation- sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circula-tion, 100, 717–722.
   Google Scholar
• DE BREE, A., VERSCHUREN, W. M., KEomuou-r, D., KwirrmANs, L. A. and Bwm, H. J. 2002, Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev, 54, 599–618.
   Google Scholar
• DECENSI, A., OMODEI, U., ROBERTSON, C., BONANNI, B., GTJERRIERI-GONZAGA, A., RAMAZZOTTO, F., JOHANSSON, H., MORA, S., SANDRI, M. T., CAZZANIGA, M., FRANCHI, M. and PECORELLI, S. 2002, Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women. Circulation, 106, 1224–1228.
   Google Scholar
• DEmum, K, Moxrri, N., HANON, 0., BENorr, M. 0., SAFAR, M. and GIRERD, X. 1998, Opposite effects of plasma homocysteine and the methylenetetrahydrofolate reductase C677T mutation on carotid artery geometry in asymptomatic adults. Arterioscler Thromb Vasc Biol, 18, 1838–1843.
   Google Scholar
• ENGBERSEN, A. M., FRANKEN, D. G., BOERS, G. H., STEVENS, E. M., TRIJBELS, F. J. and Bwm, H. J. 1995, Thermolabile 5,10- methylenetetrahydrofolate reductase as a cause of mild hyperhomo-cysteinemia. Am I Hum Genet, 56, 142–150.
   PubMed Web of Science ®Google Scholar
• FoRD, E. S., GALUSKA, D. A., GU T FSPIE, C., WILL, J. C., GILES, W. H. and DIETZ, W. H. 2001, C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. I Pediatr, 138, 486–492.
   Google Scholar
• FROSST, P., BLOM, H. J., MuoS, R, GOYETTE, P., SHEPPARD, C. A., MATTHEWS, R G., BOERS, G. J., DEN HEUER, M., KEtarrmANs, L A. and VAN DEN HEUVEL, L P. 1995, A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 10, 111–113.
   Google Scholar
• HAVERKATE, F., THOMPSON, S. G., PYKE, S. D., GALT-MORE, J. R and PEPYS, M. B. 1997, Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet, 349, 462–466.
   Google Scholar
• JARVISALO, M. J., HARMOINEN, A., HAKANEN, M., PAAKKUNAINEN, U., VIIKARI, J., HARTIALA, J., LEirrimAKI, T., SuviELL, 0. and RArrAKAEL 0. T. 2002, Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol, 22, 1323–1328.
   Google Scholar
• Liuzzo, G., BIASUCCI, L. M., GALT-MORE, J. R., GErtio, R. L., REBUZZI, A. G., PEPYS, M. B. and MASERI, A. 1994, The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl I Med, 331, 417–424.
   Google Scholar
• MACY, E. M., HAYES, T. E. and TRACY, R P. 1997, Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem, 43, 52–58.
   PubMed Web of Science ®Google Scholar
• MENDALL, M. A., PATEL, P., BALLAM, L, STRACHAN, D. and NORTHFIELD, T. C. 1996, C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BM/, 312, 1061–1065.
   PubMed Web of Science ®Google Scholar
• MILLER, A. P., CHEN, Y. F., XING, D., FENG, W. and OPARIL, S. 2003, Hormone replacement therapy and inflammation: interactions in cardiovascular disease. Hypertension, 42, 657–663.
   PubMedGoogle Scholar
• MISR AA. 2000, Risk factors for atherosclerosis in young individuals. I Cardiovasc Risk, 7, 215–229.
   PubMedGoogle Scholar
• PRADHAN, A. D., MANSON, J. E., Rossouw, J. E., SISCOVICK, D. S., MOUTON, C. P., RIFAI, N., WALLACE, R B., JACKSON, R D., PETTINGER, M. B. and RIDKER, P. M. 2002, Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA, 288, 980–987.
   PubMed Web of Science ®Google Scholar
• REFSUM, H., UELAND, P. M., NYGARD, 0. and VOLISET, S. E. 1998, Homocysteine and cardiovascular disease. Annu Rev Med, 49, 31–62.
   Google Scholar
• REYNOLDS, G. D. and VANCE, R P. 1987, C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med, 111, 265–269.
   PubMedGoogle Scholar
• RIDKER, P. M., CUSHMAN, M., STAMPFER, M. J., TRACY, R P. and HENNEKENS, C. H. 1997, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl I Med, 336, 973–979.
   PubMed Web of Science ®Google Scholar
• RIDKER, P. M. 1998, Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? Circulation, 97, 1671–1674.
   PubMed Web of Science ®Google Scholar
• SRINIVASAN, S. R., EHNHOLM, C., WATTIGNEY, W. A. and BERENSON, G. S. 1996, Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study. Atherosclerosis, 127, 73–79.
   PubMedGoogle Scholar
• TAKAMURA, N., KONDOH, T., OHGI, S., ARISAWA, K., MINE, M., YAMASHITA, S. and AOYAGI, K. 2004, Abnormal folic acid/homocysteine metabolism as maternal risk factors for Down syndrome in Japan. European Journal of Nutrition, 43, 285–287.
   PubMedGoogle Scholar
• VLKRAM, N. K., MISRA, A., DWIVEDI, M., SHARMA, R, PANDEY, R. M., LUTHRA, K, CHATTERJEE, A., DHINGRA, V, Nilo-1Am, B. L., TAI-WAR, K. K. and GULERIA, R. 2003, Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis, 168, 305–313.
   Google Scholar
• VISSER, M., BotrrER, L. M., McQuaLAN, G. M., WENER, M. H. and HARRIS, T. B. 2001, Low-grade systemic inflammation in overweight children. Pediatrics, 107, E13—E18.
   Google Scholar
• VONGPATANASIN, W, TUNCEL, M., WANG, Z., ARBIQUE, D., MEHRAD, B. and JIALAL„ I. 2003, Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. I Am Coll Cardiol, 41, 1358–1363.
   Google Scholar